Le Lézard
Classified in: Health
Subjects: MAV, DIS, SCZ, CFG, DEI

NOTICE TO THE MEDIA - Government of Canada to make an announcement supporting long-term care in Quebec


MONTRÉAL, June 26, 2022 /CNW/ -The Honourable Jean-Yves Duclos, Minister of Health, and Member of Parliament for Bourassa, Emmanuel Dubourg, will make an important funding announcement supporting long-term care in Quebec.

There will be a media availability immediately following the announcement.

Date
June 27, 2022

Time
11:15 AM (EDT)

Location

The event will be held in-person at:

Club de l'âge d'or Sainte-Colette
Sainte-Colette Church
11905 Sainte-Colette Blvd.
Montréal-Nord
H1G-4T9

Media may also join by Zoom:
https://ca01web.zoom.us/j/62304658240

Passcode:  110880

Please indicate your name (first and last) and media outlet when joining the event.

SOURCE Health Canada


These press releases may also interest you

at 08:10
Sangamo Therapeutics, Inc. , a genomic medicines company, today presented pre-clinical data showcasing its novel next-generation integrase technology engineered to enable large-scale genome editing. Building on Sangamo's deep expertise in protein-DNA...

at 08:09
Aquilance, a leading provider of financial administration services for high-net-worth families, individuals, and family offices, continues to gain recognition for its proprietary technology and white glove service. This year, the firm is proud to...

at 08:06
Academy Sports + Outdoors ("Academy") today announced the donation of over $530,000 to St. Jude Children's Research Hospital®. The donation is a result of a collaboration between the two organizations to create holiday-inspired t-shirts and pajamas...

at 08:05
Researchers from Mind Medicine (MindMed) Inc. (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today presented new studies highlighting the significant...

at 08:05
ECI is thrilled to unveil its strategic rebranding, which combines Enhanced Compliance, Inc. and its Costa Rica-based subsidiary CRx Life Sciences into one entity and signals a critical juncture in the company's ongoing growth and dedication to...

at 08:05
Edgewise Therapeutics, Inc., , a leading muscle disease biopharmaceutical company, today reported financial results for the first quarter of 2024 and recent business highlights. "2024 is off to a great start with tremendous progress on our skeletal...



News published on and distributed by: